Assignee
BEIJING BIO TARGETING THERAPEUTICS TECH INC
CN·3 granted patents·1 pending application·9 citations·filing 2016–2022
Top patents by PatentIndex Score
4 records- 0188US10294493B2Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the sameBEIJING BIO TARGETING THERAPEUTICS TECH INC·Filed 2018·Granted May 21, 2019·8 cites·2 claims
- 0267US11345732B2Modified interleukin 12 and use thereof in preparing drugs for treating tumoursBEIJING BIO TARGETING THERAPEUTICS TECH INC·Filed 2016·Granted May 31, 2022·1 cites·5 claims
- 0355US2022213161A1Modified interleukin 12 and use thereof in preparing drugs for treating tumoursBEIJING BIO TARGETING THERAPEUTICS TECH INC·Filed 2022·Application pending·0 cites
- 0453US9932606B2Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the sameBEIJING BIO TARGETING THERAPEUTICS TECH INC·Filed 2016·Granted Apr 3, 2018·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when BEIJING BIO TARGETING THERAPEUTICS TECH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →